We have shown that platelets are capable of phagocytosing liposomes rather than simply sequestering par- membrane marker. Uptake was inhibited by the addition of EDTA, cytochalasin B, or 2,4-dinitrophenol and iodoacetate to the medium. Results from the serotonin release assay, microaggregation assay, fluorescein diacetate membrane integrity assay, and electron microscopy indicate that neither the conditions for loading nor phagocytosis ofliposomes significantly alter platelet function or morphology.
platelet were taken up within a 5-hr incubation period. Uptake of the liposomes occurred through the open-channel system, as evidenced by thin-section electron microscopy, and was followed by accumulation and degradation in acid-and esterasecontaining vesicles, as determined by changes in fluorescence of the pH-sensitive probe, pyranine (1-hydroxypyrene-3,6,8-trisulfonic acid), and hydrolysis of the cholesteryl ['4Cloleate membrane marker. Uptake was inhibited by the addition of EDTA, cytochalasin B, or 2,4-dinitrophenol and iodoacetate to the medium. Results from the serotonin release assay, microaggregation assay, fluorescein diacetate membrane integrity assay, and electron microscopy indicate that neither the conditions for loading nor phagocytosis ofliposomes significantly alter platelet function or morphology.
Platelets have been shown to take up a variety of particles in vitro (1) (2) (3) (4) (5) (6) and evidence is accumulating which suggests that removal of foreign materials from the blood may be an important physiologic role for these cells (7) (8) (9) (10) . However, it remains to be definitively demonstrated whether platelets are truly phagocytic or simply sequester the particles within the open-channel system (OCS).
In prior work, the platelet-latex sphere system has been used as a model for foreign particle ingestion by these cells (2, 3, (11) (12) (13) . Various studies have shown progressive accumulation of latex spheres in the OCS, a system of channels believed to be formed by invagination of the plasma membrane. Lewis et al. (13) noted subsequent localization of the particles in acid phosphatase-positive electron-opaque vacuoles and concluded that platelets phagocytose latex particles. However, White (12) concluded that platelets sequester latex particles within membrane invaginations, which are in communication with the exterior of the cell. We report the use of small neutral unilamellar liposomes to study possible phagocytosis of particles by platelets. Liposomes have been used extensively to model microorganism interactions and, unlike latex beads, are more suitable for the study of uptake, metabolism, and exocytosis.
MATERIALS AND METHODS Purification of Platelets. Platelets were prepared by two methods; experiments measuring uptake using either platelet preparation gave similar results. Platelet-rich plasma packs obtained from the Red Cross were diluted in a 1:1 ratio with 0.9%o saline solution. A volume of 4.5% dextran (Mr, 250, 000) in saline solution was added to an equal volume of the diluted packs and stirred; erythrocytes were allowed to sediment for 30 min at room temperature. Fifteen-milliliter aliquots of the supernatant were pipetted into centrifuge tubes. Equal volumes of a solution containing 6.35% Ficoll and 10o Hypaque (wt/wt) were gently layered on the bottom of the tubes. The tubes were spun at 400 x g for 15 min at room temperature. The cloudy band containing the platelets and lymphocytes located directly above the Ficoll/Hypaque gradient was gently removed, diluted in a 1:1 ratio with saline solution, and centrifuged at 300 x g for 15 min at room temperature to sediment the lymphocytes. The supernatant was spun at 800 x g for 20 min; the platelet pellet formed was washed twice in saline solution and finally resuspended in Hanks' balanced salt solution (HBSS).
Platelets purchased from the American Blood Institute (Los Angeles) were centrifuged at 1000 x g for 15 min in an IEC Centra-8 centrifuge. The pellet was resuspended in either 0.9%o saline solution or Tyrode's buffer and was spun at 110 x g for 5 min to remove excess erythrocytes. The supernatant was spun at 450 x g for 10 min. The pellet was resuspended in HBSS or modified Tyrode's buffer (Tyrode's buffer plus 1.26 mM CaCl2).
The final purities of both platelet preparations were >95% platelets as assessed by a Coulter S + 4 Cell Counter; the main contaminants were erythrocytes. Platelets were used within 24 hr of blood collection.
Determination (18) .
Thin-Sectlon Electr Microscopy. Samples of 3 x 10V platelets were incubated with 7 x 1011 nonradiolabeled liposomes for 6 hr at 370C, fixed in a standard fashion, and embedded in LR white.
In addition, platelets suspended in HBSS or modified Tyrode's buffer incubated with or without liposomes for 1 hr at 3TC prepared as described above were studied to determine changes in platelet morphology under the conditions used for studying the liposome interaction.
In Vitro Studies to Assess Platelet Function. Serotonin release assay. The serotonin assay was performed with 3 x 10V platelets suspended in HBSS or in modified Tyrode's solution and incubated with or without 1.4 x 1012 liposomes for 1-9 hr as described (19 FDA is a nonfluorescent probe that readily crosses the cell membrane. Within the cell the probe is hydrolyzed by esterases to form fluorescent fluorescein, which does not readily traverse the cell membrane at 40C but can leak out of the cells through membrane lesions. Therefore, the leakage of fluorescein is a measure of loss of membrane integrity (20) .
RESULTS
[3flChoesterylbexadecyl Ether-Labeled Liposome Uptake.
To model the liposome uptake by platelets, [3H]cholesterylhexadecyl ether-labeled liposome uptake was studied for various incubation times and incubation concentrations of both the liposomes and platelets. Platelet uptake of [3H]cholesterylhexadecyl ether-labeled liposomes increased with increasing incubation times (Fig. 1) . After incubation of 3 x 108 platelets with 7 x 1011 liposomes for 5 hr, =250 liposomes were associated with each platelet. Liposome uptake by platelets also increased with increasing numbers of incubated liposomes; two incubation times are shown (Fig. 2) . Incubation for 12.5 hr resulted in greater uptake values than the 2.0-hr incubation. As the number of platelets incubated with a constant amount of liposomes was increased, the overall number of liposomes incorporated increased (Fig. 3) (Fig. 6 ). After 12 hr no membraneassociated probe was released. However, up to 60% of the aqueous-phase probe was released during this period.
HPTS-Labeled Liposome Uptake. To determine the percentage of liposomes phagocytosed and delivered to acidic compartments, the uptake of fluorescently labeled (HPTS) liposomes was measured by fluorimetry versus time (Fig. 7) . Initially, the liposomes were associated with the platelets, either bound to the surface or contained in the OCS, but were not phagocytosed. Within released by the cells. Therefore, the increase in the 3H/14C ratio in the cells was indicative of degradation of the liposomes. The amount of liposome degradation is probably underestimated since incubations were done in the absence of serum, which is unfavorable for the release of oleate (21) .
Electron Microscopy. Electron microscopy was performed to study the effects of HBSS and modified Tyrode's solution and the phagocytosis of liposomes on platelet morphology (n = 4). The effects of incubation of up to 2.1 x 1012 liposomes were studied.
Platelets maintained a discoid shape when suspended in modified Tyrode's buffer. However, platelets suspended in HBSS tended to have irregular shapes and approximately half had pseudopodia. Therefore, we believe that incubation in modified Tyrode's buffer is superior. Incubation with liposomes did not significantly alter platelet morphology.
Competitive Assay. A competitive assay was performed to establish whether liposome uptake could be saturated. Preincubation of platelets with 0-3.4 x 1012 nonradiolabeled liposomes prior to two centrifugation washes and incubation with 7.9 x 1011 tritiated liposomes for preincubation times of for various incubation times. Cells were then pelleted, washed twice in buffer, and resuspended in buffer. Percentages of plateletassociated liposomes phagocytosed were calculated (n = 6). 0.5, 2, and 6 hr and incubation times of 0.17, 0.5, 2, and 6 hr gave similar results (data not shown; n = 4). The amount of
[3H]cholesterylhexadecyl ether liposomes taken up was independent of the amount of nonradiolabeled liposomes previously added. In addition, uptake was relatively independent of the preincubation time, while uptake increased with increasing incubation times. Simultaneous incubation ofnonradiolabeled and 3H-labeled liposomes resulted in a linear decrease in uptake of the 3H-labeled liposomes as expected.
Inhibition of Liposome Uptake. The inhibitory effects of a variety of reagents known to decrease platelet uptake oflatex spheres were examined during platelet incubation with liposomes. Incubation for 12 hr in the presence of 5 mM EDTA inhibited the uptake of liposomes by 48% + 91%; however, incubation for 1 hr showed no significant inhibition of uptake (n = 10). The addition of cytochalasin B (10 pg/ml) (n = 8) or 0.25 mM 2,4-dinitrophenol with 50 juM iodoacetate (n = 8) also inhibited uptake by 46% ± 16% and 66% ± 12%, respectively.
In Vitro Assays to Assess Platelet Function. Although the numbers of liposomes phagocytosed by platelets suspended in HBSS or modified Tyrode's buffer are identical, the in vitro assays showed that platelets, incubated with or without liposomes, spontaneously secrete serotonin, aggregate, and lose membrane integrity more while suspended in HBSS. However, phagocytosis of liposomes did not significantly alter platelet secretion of serotonin or induce additional platelet aggregation or loss of membrane integrity. This was not surprising since it had been previously shown that the uptake of Intralipid, a lipid emulsion used in treatment of patients with deficient caloric intake, does not increase platelet aggregation or induce morphological changes (22) . DISCUSSION We have determined that platelets are capable of phagocy- differentiate between incorporated and bound liposomes. However, according to electron micrographs, the vast majority of the liposomes appear to be within the OCS. In addition, the use of a pH-dependent fluorescent liposome probe confirms that a substantial portion of the liposomes are phagocytosed and are in acid-containing compartments. These data suggest that the liposomes are incorporated in surface invaginations, which pinch off their connections to the cell membrane and migrate into the cytoplasm as sealed vesicles, rather than being sequestered in the OCS and in contact with the outside medium. Degradation of the liposomes, which probably occurs in the acid phosphatase-and esterase-containing vacuoles, has also been demonstrated by utilizing cholesteryl [14C]oleate-labeled liposomes. The mechanism for release of the aqueous components to the outside of the cell probably involves migration of these vacuoles to the periphery of the cell and exocytosis of their contents; however, this has not been confirmed. Although the space available for uptake within the cell must be limited, exocytosis ofthe aqueous components ofthe liposomes increases the amount of liposome lipid capable of being stored as detected by the [3H]cholesterylhexadecyl ether label. With the amounts of liposomes and platelets used and on the time scale of the preincubation experiments, the space available for uptake is not saturable. The uptake is independent of the amount of nonradiolabeled liposomes added and of preincubation times. Simultaneous incubation of nonradiolabeled and radiolabeled liposomes demonstrates a dilution effect, which results in decreased uptake of the radiolabeled liposomes.
According to Mustard and Packham (3) , the addition of EDTA inhibits phagocytosis of particles and platelet aggregation, but it does not interfere with particle adherence. Liposome uptake is inhibited by the presence of EDTA at long time intervals but not at short intervals when the predominant process ofuptake in the absence of Ca2+ may be binding. This evidence suggests that divalent cations are involved in the phagocytosis process; however, the effects of different divalent cations have not been investigated. The inhibitory effect of cytochalasin B with respect to platelet uptake has been attributed to its effect on microfilaments and the plasticity of the platelet membrane (23) . The addition of 2,4-dinitrophenol and iodoacetate before incubation blocks aggregation and phagocytosis by interfering with glycolysis and oxidative phosphorylation (2) . Liposome uptake is Ca2+ dependent; however; platelets tend to aggregate and secrete more in the presence of Ca2+. Therefore, we studied the effects of HBSS and modified Tyrode's buffer on the morphology and function of platelets, which both contained 1.26 mM CaC12. The serotonin release assay, microaggregation assay, and FDA membrane integrity assay all show that platelet function and morphology are better preserved in modified Tyrode's buffer than in HBSS. However, even in modified Tyrode's buffer, the loss of membrane integrity is significant. This loss may be due to incubation of the platelets in small polypropylene centrifuge tubes at 37°C. It is preferable to store platelets at room temperature, but phagocytosis is maximized at 37°C. The assays also indicated that phagocytosis of liposomes does not adversely affect the platelets.
Although we began this research to define the mechanisms involved in platelet-liposome interactions, we realize the ability to encapsulate a variety of drugs or radioactive labels in vitro in platelets and to target specific locations in vivo such as areas of inflammation or infection, neoplastic tumor cells, or thrombosis would be of great medical importance. The exocytosis process is comparatively rapid; the half-life of the aqueous compartment calculated assuming a first-order reaction is 3.9 hr. Therefore, it may be necessary to use inhibitors that would slow the digestion of the liposomes or the release of the liposomes' aqueous components. Alternatively, lipid analogs of the drugs could be used for longer platelet retention. In some cases, rapid release of drugs from the aqueous compartments may be desirable. An example of this might be the delivery of thrombolytic agents to a coronary thrombus in the initial treatment of myocardial infarction.
